Live Breaking News & Updates on Prnewswire Genprex Inc|Page 1

Stay updated with breaking news from Prnewswire genprex inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Kalyn Dabbs , Rodney Varner , Genprex Inc , Prnewswire Genprex Inc , Company Website , Drug Administration Fast Track Designations , Exchange Commission , Chief Executive Officer , Confer Appointed Genprex President , Orphan Drug , Chief Financial Officer , Chief Operating , Financial Officer , Delivery System , Immunogene Therapy , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market ,

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Rodney Varner , Drug Administration Fast Track Designations , Prnewswire Genprex Inc , Exchange Commission , Genprex Inc , Company Website , Ryan Confer Appointed Genprex President , Chief Executive Officer , Orphan Drug , Chief Financial Officer , Chief Operating , Financial Officer , Delivery System , Immunogene Therapy , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market ,

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a. ....

United States , Genentech Tecentriq , Mark Berger , Kalyn Dabbs , Rodney Varner , Exchange Commission , Drug Administration , Genprex Inc , Prnewswire Genprex Inc , Company Website , Expands Clinical Trial Sites , Treat Small Cell Lung , Fast Track , Immunogene Therapy , Chief Executive Officer , Chief Medical Officer , Maximum Tolerated Dose , Recommended Phase , Ophran Drug , Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market ,

Genprex Announces Closing Of $6.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Genprex Announces Closing Of $6.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Kalyn Dabbs , Exchange Commission , Prnewswire Genprex Inc , Genprex Inc , Securities Exchange , Delivery System , Immunogene Therapy , Fast Track Designation , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Current Reports ,

Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

United States , Genprex Inc , Vstock Transfer , Company Website , Company Board Of Directors The , Exchange Commission , Company Board , Prnewswire Genprex Inc , Nasdaq Capital , Nanoparticle Delivery System , Immunogene Therapy , Fast Track Designation , Language Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market , Health Care Amp Hospitals , Medical Pharmaceuticals , Stock Split ,